Actavis Puts Greater Emphasis On Branded Rx By Taking Allergan Name

The growing spec pharma has seen a 300% increase in its branded portfolio revenues since the acquisition of Forest and Warner Chilcott and is honoring the new direction by taking on the name of its most recent acquisition.

More from Archive

More from Pink Sheet